Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-041640
Filing Date
2022-02-14
Accepted
2022-02-14 16:06:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d284359dsc13g.htm SC 13G 38472
  Complete submission text file 0001193125-22-041640.txt   39820
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address
ARMEN GARO H (Filed by) CIK: 0000935679 (see all company filings)

Type: SC 13G

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Subject) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92968 | Film No.: 22631493
SIC: 2836 Biological Products, (No Diagnostic Substances)